Details of Bacterial Vaccine
This bacterial vaccine card gives comprehensive information about each vaccine.
Detailed Information | |
---|---|
ID | 1185 |
Name of the vaccine | CTH522 (CHLM-02) |
Microbe | Bacteria |
Disease name | Trachoma |
Name of bacteria | Chlamydia trachomatis |
Type of vaccine | Recombinant |
Nucleic acid content | DNA |
Age | 18 to 45 years |
Description of the vaccine | Chlamydia vaccine. |
Name of the manufacturer | Statens Serum Institut |
Name of the manufacturing country | United Kingdom |
Year of manufacture | 2022 |
Clinical Phase status | Clinical - Phase 1 |
Bacterial strain | Gram-negative bacterium. |
Efficacy | NA |
Vaccine formulation | NA |
Dosage | Three doses. |
Mechanism of action | Anti-CTH522 IgG seroconversion. |
Route of administration | Intramuscular |
Indications | NA |
Export | NA |
Approval | NA |
Adjuvant | CAF09b, CAF01 |
Repurposing | For chlamydia. |
Side effects of vaccine | Mild local injection-site reactions. |
Post vaccination | NA |
Dose type | Combination doses |
Interspecies transfer | NA |
PubMed identifier | 31416692 |
Clinical trial number | NCT03926728 |
Reference | NA |
Other name | NA |
Additional Links | NA |